Aug 8, 2019, 11:09 AM by Michael Croft

HOPKINTON, MA, UNITED STATES - Aug 8, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, announced that its Investigational New Drug (IND) application for a Phase 1 trial of SB 11285, the company’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist development candidate, is now effective following clearance by the FDA

Aug 8, 2019, 10:44 AM by Michael Croft

PRINCETON, NJ - Aug 8, 2019 - The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced the acquisition of PharmaSeek, LLC, including its wholly-owned subsidiaries PFS Clinical and PatientWise, leading providers of turn-key administrative, consulting, patient recruitment and training solutions for clinical research sites

Aug 7, 2019, 10:12 AM by Michael Croft

CAMBRIDGE, MA, US - Aug 7, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that it has been honored with two GHP International Life Sciences Awards – Best Clinical Trials Wearable Sensor Technology Company USA, and Best Researcher Wearable Wireless Technology Provider 2019

Aug 7, 2019, 08:09 AM by Michael Croft

WESTBURY, NY - Aug 7, 2019 - Aug. 7, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a research symposium entitled "Innovation in Immuno-oncology: Breaking Down the Barriers" on Aug

Aug 6, 2019, 13:55 PM by Michael Croft

BERLIN, GERMANY - Jul 30, 2019 - LabTwin GmbH, the world’s first voice and AI-powered digital lab assistant, today announced partnerships with CA-based life science shared lab facilities Bonneville Labs and Lab Launch

Aug 6, 2019, 10:23 AM by Michael Croft

PRINCETON, NJ - Aug 6, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of BaseCase Data Manager, which allows clients to build interactive, data-driven mobile tools using real-world data sources, such as healthcare claims, costs, quality, outcomes, and population data

Aug 6, 2019, 08:43 AM by Michael Croft

WESTBURY, NY - Aug 6, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc

Aug 5, 2019, 15:28 PM by Michael Croft

BEVERLY, MA, UNITED STATES - Aug 5, 2019 - Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the Wisconsin State Laboratory of Hygiene has adopted its technology to improve newborn screening for Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiency (SCID)

Aug 5, 2019, 11:55 AM by Michael Croft

Aug 1, 2019, 09:04 AM by Michael Croft

PLYMOUTH MEETING, PA - Aug 1, 2019 - Signant Health (formerly CRF Health and Bracket) today announces that its Senior Vice President, Dr. David Daniel, has been selected by PharmaVOICE as one of the top 100 most inspiring people within the life sciences sector

Jul 31, 2019, 11:30 AM by Michael Croft

Bio-IT World | July featured exciting news, products, and partnerships from around the bio-IT community including CRISPR patents, Oxford Nanopore, the first high-resolution sequence of the Komodo dragon, and more.

Jul 31, 2019, 09:48 AM by Michael Croft

SAN DIEGO, CA - Jul 31, 2019 - San Diego, CA . . . . Binding Site’s IMMUNOLOGICALS GROUP is pleased announce that it has just completed a major expansion to their antibody and antigen product offerings for human Coagulation testing applications

Jul 30, 2019, 10:44 AM by Michael Croft

NEW YORK, NY - Jul 30, 2019 - BetterPT™, a healthcare technology platform company providing end-to-end digital connectivity between physical therapists (PT), patients, and physicians, and BlueJay Mobile Health, a full-service mobile technology company transforming healthcare delivery and care team coordination through AI-powered telehealth, today announced a partnership to bridge patients, PTs and healthcare providers through the full continuum of care

Jul 30, 2019, 10:17 AM by Michael Croft

BOSTON, MA, UNITED STATES - Jul 30, 2019 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that OHSU in Portland, Oregon, a nationally distinguished research organization, will utilize the Kyruus ProviderMatch® platform to enhance patient access to providers and services across the OHSU health system

Jul 30, 2019, 10:10 AM by Michael Croft

GUILDFORD, UNITED KINGDOM - Jul 30, 2019 - MR Solutions has received the prestigious Queen’s Award for Enterprise in recognition of the company’s innovative PET imaging technology for use in pre-clinical research

Jul 30, 2019, 10:07 AM by Michael Croft

CAMBRIDGE, MA, US - Jul 30, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced that the European Commission (EC), based on a favorable recommendation from the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation (ODD) to mavorixafor (X4P-001) for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome, a rare, inherited, primary immunodeficiency disease caused by genetic mutations in the CXCR4 receptor gene

Jul 30, 2019, 09:06 AM by Michael Croft

BOWIE, MD - Jul 30, 2019 - Start-up Trinity Cyber achieved a major milestone with its closure today on $23 million in funding from top institutional investors led by Intel Capital

Jul 30, 2019, 08:15 AM by Michael Croft

PRINCETON, NJ - Jul 30, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of version 19

Jul 30, 2019, 07:00 AM by Michael Croft

Jul 29, 2019, 22:44 PM by Michael Croft

SHIRLEY, NY, NY, UNITED STATES - Jul 30, 2019 - The world's leading chemical vendor BOC Sciences announces at its headquarter in New York to release a featuring inhibitor chemical – eribulin – for researchers who are involved with breast cancer research in the pharmaceutical industry